Ether of phosphatidylcholine and phosphatidylethanolamine, their lyso-forms and mixture thereof for use in the treatment of a disease or disorder caused by a deficiency in plasmalogens
AssigneesBaker Heart and Diabetes Institute, Pelagic AI Limited
InventorsPeter J. Meikle, Paul Sudip, Amy Boileau, Martin Ducker, Kevin Huynh
Life of this patent
Estimating the term…
Abstract
The disclosure relates to certain compounds that can be consumed by a human subject to modulate the levels of plasmalogens in the subject to provide improved health outcomes. The disclosure further relates to the formulation of said compounds, compositions comprising at least one compound, and uses thereof.
Claims161
A composition comprising at least one compound of Formula (I) or a pharmaceutically acceptable salt thereof
The composition of any preceding claim, wherein the composition comprises a mixture of at least two compounds of Formula (I) and/or (I-A).
The composition of any preceding claim, wherein the composition comprises a mixture of three compounds of Formula (I) and/or (I-A).
Dependencies are inferred from the claim text.